CONFIDENTIAL — APPROVED FOR PUBLIC RELEASE · BUREAU FILE COPY RECORDS CURRENT AS OF 29 MAY 2026 · DISTRIBUTION: UNRESTRICTED
VendorInvestigate Independent Testing Bureau · Public Records Division
DOCKET YEAR 2026 · VOL. II
13,421 SAMPLES ON FILE
No fee · No favor
Compound Evidence File
#EC-2026-0129

BMK glycidic acid (free acid) CAS 25547-51-7

Filed under Raw Materials. The bureau holds 75 laboratory returns for this compound from 20 distinct subjects. Scores below are per-subject aggregates; open a subject row for the underlying evidence.

Cross-Index

Subjects Shipping This Compound

20 SUBJECTS
SubjectGradeSamplesMeanMinMaxFirst seenLast seen
Tianjin Finder Chemical TFCCASE #VI-2026-0693A610.09.910.014 Nov 202516 Apr 2026
HomopeptideCASE #VI-2026-0760A510.09.910.023 May 202623 May 2026
Bulk Peptide WholesaleCASE #VI-2026-0319A29.29.29.37 May 202525 May 2026
Wuhan Wansheng Bio (WWB)CASE #VI-2026-0594A29.19.19.221 May 202621 May 2026
Shanghai Sigma Audley SSACASE #VI-2026-0486A78.56.89.224 May 202624 May 2026
Qingdao Sigma Chemical QSCCASE #VI-2026-0538A58.47.59.724 May 202624 May 2026
Nantong Guangyuan Chemical GYCCASE #VI-2026-0284A28.38.28.424 May 202624 May 2026
Glbiochem (Shanghai)CASE #VI-2026-0704A58.07.49.023 May 202623 May 2026
Bulk Peptide SupplyCASE #VI-2026-0446X28.06.79.325 Apr 202524 May 2026
Guangzhou Lengiuanhuang CosmeticsCASE #VI-2026-0228X17.57.57.513 Jun 202513 Jun 2025
HK PeptidesCASE #VI-2026-0140X157.12.510.02 Jul 202520 May 2026
ZZQ PeptidesCASE #VI-2026-0550X17.07.07.013 Feb 202513 Feb 2025
ZLZ PeptideCASE #VI-2026-0524X146.93.69.53 Jul 202520 May 2026
Hunan Ruiwang Technology CenterCASE #VI-2026-0027X16.36.36.328 Mar 202528 Mar 2025
Simple PeptideCASE #VI-2026-0782X26.05.16.928 Mar 202517 May 2026
Haikou Mingheng TechnologyCASE #VI-2026-0250X15.85.85.813 Jun 202513 Jun 2025
Shaanxi Dideu MedichemCASE #VI-2026-0499X15.65.65.627 Feb 202527 Feb 2025
Regenerative ResearchCASE #VI-2026-0349X15.45.45.413 Jun 202513 Jun 2025
Liberty PeptidesCASE #VI-2026-0416X15.35.35.324 Apr 202524 Apr 2025
Peptides 4 ResearchCASE #VI-2026-0511X23.12.83.48 Jul 202519 Jan 2026

Open any subject to view the batch-level evidence for BMK glycidic acid (free acid) CAS 25547-51-7 alone.